Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER

ClinicalTrials.gov ID: NCT00578708

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00578708. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:50 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this feasibility study is to investigate the safety of the AMPLATZER® Membranous VSD Occluder for the treatment of hemodynamically significant Perimembranous Ventricular Septal Defects.

Study identification

NCT ID: NCT00578708
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Abbott Medical Devices; Industry
Enrollment: 35 participants

Conditions and interventions

Conditions

Membranous Ventricular Septal Defects

Interventions

AMPLATZER Membranous VSD Occluder Device

Device

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2003 (Type not available)
Primary completion: Mar 2010 (Actual)
Completion: Sep 2010 (Actual)
Last update posted: Feb 4, 2019

2003 – 2010

United States locations

U.S. sites: 6
U.S. states: 6
U.S. cities: 6

Facility	City	State	ZIP	Site status
University of Minnesota	Minneapolis	Minnesota	55455	—
Washington University Medical Center	St Louis	Missouri	63110	—
Children's Hospital UN/CU)	Omaha	Nebraska	68114	—
Columbia University	New York	New York	10032	—
Columbus Children's Hospital	Columbus	Ohio	43205	—
Medical University of South Carolina	Charleston	South Carolina	29425	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00578708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 4, 2019 · Synced Nov 14, 2026